Despite several studies characterizing the molecular alterations in meningiomas, they do not impact the classification with two exceptions: TERT promoter mutations and the homozygous deletion of CDKN2A/B have been associated with a more aggressive clinical behavior and their presence suffices for a grade 3 classification even if the histopathology does not meet the criteria [10,11]. Here, TERT is linked to meningioma.